carbidopa has been researched along with Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awad, N; Roy, D; Song, J; Zamudio, P | 1 |
| Du, YS; Guo, HM; Hu, KR; Hu, YZ; Li, CJ; Liang, Y; Sun, H; Wang, GJ; Wang, H; Xie, L; Xu, WS; Yu, TJ | 1 |
2 other study(ies) available for carbidopa and Ischemic Stroke
| Article | Year |
|---|---|
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19.
Topics: Blood Coagulation; Brain Diseases; Carbidopa; Central Nervous System Stimulants; Cognitive Dysfunction; COVID-19; Critical Care; Drug Combinations; Humans; Hypokinesia; Ischemic Stroke; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Modafinil; Rehabilitation; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Ventilator Weaning | 2021 |
Exogenous glutathione exerts a therapeutic effect in ischemic stroke rats by interacting with intrastriatal dopamine.
Topics: Animals; Carbidopa; Cytokines; Disease Models, Animal; Dopamine; Glutathione; Homocystine; Infarction, Middle Cerebral Artery; Ischemic Stroke; Levodopa; Male; Oxidative Stress; Proteomics; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine 3-Monooxygenase; Up-Regulation | 2022 |